These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 12653034

  • 1. [Aldosterone and its antagonists in heart failure].
    Lopes ME, Le Corvoisier P, Tabet JY, Su JB, Badoual T, Cachin JC, Merlet P, Castaigne A, Hittinger L.
    Presse Med; 2003 Jan 18; 32(2):79-87. PubMed ID: 12653034
    [Abstract] [Full Text] [Related]

  • 2. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
    MMW Fortschr Med; 2004 Oct 21; 146(43):58-9. PubMed ID: 15559524
    [No Abstract] [Full Text] [Related]

  • 3. [Aldosterone receptor blockade after acute myocardial infarction with heart failure].
    Bauersachs J, Ertl G.
    Med Klin (Munich); 2006 Jun 15; 101(6):458-66. PubMed ID: 16767569
    [Abstract] [Full Text] [Related]

  • 4. [Selective aldosterone blocking in heart failure. Eplerenone reduces the risk after infarction].
    MMW Fortschr Med; 2003 Oct 30; 145(44):42-3. PubMed ID: 14655506
    [No Abstract] [Full Text] [Related]

  • 5. Aldosterone antagonism in heart failure.
    Richards AM, Nicholls MG.
    Lancet; 1999 Sep 04; 354(9181):789-90. PubMed ID: 10485716
    [No Abstract] [Full Text] [Related]

  • 6. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).
    Am J Cardiol; 1996 Oct 15; 78(8):902-7. PubMed ID: 8888663
    [Abstract] [Full Text] [Related]

  • 7. [The role of aldosterone-antagonists in the treatment of congestive heart failure].
    Fügedi K.
    Orv Hetil; 2005 Apr 03; 146(14):645-8. PubMed ID: 15889538
    [Abstract] [Full Text] [Related]

  • 8. The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study.
    Pitt B, Williams G, Remme W, Martinez F, Lopez-Sendon J, Zannad F, Neaton J, Roniker B, Hurley S, Burns D, Bittman R, Kleiman J.
    Cardiovasc Drugs Ther; 2001 Jan 03; 15(1):79-87. PubMed ID: 11504167
    [No Abstract] [Full Text] [Related]

  • 9. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
    Moore TD, Nawarskas JJ, Anderson JR.
    Heart Dis; 2003 Jan 03; 5(5):354-63. PubMed ID: 14503934
    [Abstract] [Full Text] [Related]

  • 10. Selective aldosterone blockade with eplerenone in patients with congestive heart failure.
    Salam AM.
    Expert Opin Investig Drugs; 2003 Aug 03; 12(8):1423-7. PubMed ID: 12882627
    [Abstract] [Full Text] [Related]

  • 11. [Aldosterone antagonist therapy for chronic heart failure].
    Yamamoto T, Yano M.
    Nihon Naika Gakkai Zasshi; 2005 Feb 10; 94(2):262-9. PubMed ID: 15768590
    [No Abstract] [Full Text] [Related]

  • 12. Aldosterone and antialdosterone therapy in congestive heart failure.
    Weber KT, Villarreal D.
    Am J Cardiol; 1993 Jan 21; 71(3):3A-11A. PubMed ID: 8422002
    [Abstract] [Full Text] [Related]

  • 13. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C, Burch J, Suekarran S, Walker S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Lorgelly P, Fenwick L, Palmer S.
    Health Technol Assess; 2010 May 21; 14(24):1-162. PubMed ID: 20492762
    [Abstract] [Full Text] [Related]

  • 14. Eplerenone in the treatment of chronic heart failure.
    Krum H, Liew D.
    Expert Rev Cardiovasc Ther; 2004 May 21; 2(3):315-20. PubMed ID: 15151479
    [Abstract] [Full Text] [Related]

  • 15. Integrating traditional and emerging treatment options in heart failure.
    Nolan PE.
    Am J Health Syst Pharm; 2004 May 01; 61 Suppl 2():S14-22. PubMed ID: 15160834
    [Abstract] [Full Text] [Related]

  • 16. [Aldosterone blockade in heart failure. So much for so little].
    González-Juanatey JR, Mazón Ramos P.
    Med Clin (Barc); 2002 Jun 01; 118(20):779-81. PubMed ID: 12049694
    [No Abstract] [Full Text] [Related]

  • 17. New treasures from old? EPHESUS. Eplerenome Post-AHI Heart Failure Efficacy and Survival Study.
    Pfeffer MA.
    Cardiovasc Drugs Ther; 2001 Jan 01; 15(1):11-3. PubMed ID: 11504157
    [Abstract] [Full Text] [Related]

  • 18. ACE inhibitor co-therapy in patients with heart failure: rationale for the Randomized Aldactone Evaluation Study (RALES).
    Pitt D.
    Eur Heart J; 1995 Dec 01; 16 Suppl N():107-10. PubMed ID: 8682055
    [Abstract] [Full Text] [Related]

  • 19. New treatment option for heart failure patients: eplerenone.
    Southworth MR, Cavallari LH.
    J Cardiovasc Nurs; 2004 Dec 01; 19(6):390-5. PubMed ID: 15529060
    [Abstract] [Full Text] [Related]

  • 20. The promise of selective aldosterone receptor antagonists for the treatment of hypertension and congestive heart failure.
    Hameedi A, Chadow HL.
    Curr Hypertens Rep; 2000 Aug 01; 2(4):378-83. PubMed ID: 10981173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.